Key result
Antenatal evaluation in ARRTD reveals increased renal blood flow resistance and a novel angiotensinogen mutation.
Why the study?
The fetal ultrasound characteristics, pathology, and molecular genetic etiology of autosomal recessive tubular dysplasia were not well elucidated.
Observational (n=4)
Increased renal blood flow resistance, oligohydramnios, and inadequate bladder filling on ultrasound should raise strong suspicion for ARRTD, which may be linked to a nonsense mutation in the angiotensinogen gene.
May aid antenatal ARRTD suspicion via Doppler; leaves open AGT mutation implications pending larger studies.
OBJECTIVE: This study aimed to elucidate the fetal ultrasound characteristics, pathology, and molecular genetic etiology of autosomal recessive tubular dysplasia. METHODS: This retrospective study examined four fetuses with autosomal recessive tubular dysplasia (ARRTD) from two pregnancies, utilizing ultrasound evaluations and fetal renal pathology. Whole-exome sequencing-copy number variation analysis was employed to identify gene mutations. RESULTS: We present for the first time renal vascular resistance in fetuses with ARRTD, characterized by increased renal blood flow resistance and reversed diastolic blood flow, indicating fetal renal insufficiency. This is the first report of a nonsense mutation (C.571C>T) found in the angiotensinogen gene. CONCLUSION: ARRTD disease should be strongly suspected when ultrasound examinations reveal increased renal blood flow resistance, oligohydramnios, and inadequate bladder filling, regardless of the presence of renal abnormalities.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) conducted an observational in Autosomal recessive tubular dysplasia (ARRTD) (n=4). Antenatal ultrasound scanning and molecular investigations was evaluated on Fetal ultrasound characteristics, pathology, and molecular genetic etiology. Antenatal ultrasound and molecular investigations in 4 fetuses with ARRTD revealed increased renal blood flow resistance and a novel nonsense mutation (C.571C>T) in the angiotensinogen gene.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: